Hennion & Walsh Asset Management, Inc. Instil Bio, Inc. Transaction History

Hennion & Walsh Asset Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$0.4 - $0.63 $1,558 - $2,453	3,895 Added 4.14%	98,080 $42,000
Q2 2023 Aug 09, 2023	SELL	$0.51 - $0.67 $1,294 - $1,700	-2,538 Reduced 2.62%	94,185 $52,000
Q1 2023 Apr 20, 2023	SELL	$0.6 - $0.91 $1,834 - $2,781	-3,057 Reduced 3.06%	96,723 $64,000
Q4 2022 Jan 12, 2023	BUY	$0.48 - $5.33 $5,966 - $66,251	12,430 Added 14.23%	99,780 $63,000
Q3 2022 Nov 14, 2022	BUY	$4.65 - $7.37 $101,128 - $160,282	21,748 Added 33.15%	87,350 $423,000
Q2 2022 Jul 19, 2022	BUY	$4.21 - $11.15 $276,184 - $731,462	65,602 New	65,602 $303,000

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $2.84B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.